NSI Lab Solutions 61-00029 S. enterica Abony NCTC 6017 Pharmaceutical Culture, USP <61/62>; 10/PK

Representative image only.

NSI Lab Solutions 61-00029 S. enterica Abony NCTC 6017 Pharmaceutical Culture, USP <61/62>; 10/PK

NSI Lab Solutions | Item: 0500308

Comply with guidelines set by the USP for growth promotion and inhibitory testing

Call For Price

Call For Price
Product Description

Includes

Ten 1.5 mL vials of peptone buffer.

Key Features

  • When hydrated, activity will yield 100 CFU/100 µL
  • Stable for up to 8 hours after hydration
  • Includes sterile peptone buffer for convenience
  • No more than two passages from primary strain culture
  • ISO 17034 accredited
  • No royalty fee
  • Equivalent to WDCM 00029

More About this Item

Designed to conform with USP <61/62> specifications, culture pellet is manufactured from USP specified pure organism strain. For your convenience, each pack includes ten culture pellets individually vacuum sealed in vials and ten 1.5 mL vials of sterile peptone buffer. The culture pellet lyophilized in Microgel-Flash™ matrix dissolves almost instantly with minimum agitation and no incubation. Once hydrated in the supplied peptone buffer, these samples are stable for up to 8 hours. Extra activity listed on Certificate of Analysis (CoA). Store in the freezer.

Download Certificate of Analysis at nsilabsolutions.com/coa-downloads/.

NCTC and NCPF reference cultures obtained from the National Collection of Type Cultures and National Collection of Pathogenic Fungi, two of the culture collections of the UK Health Security Agency.
WDCM reference cultures obtained from the WFCC-MIRCEN World Data Centre for Organisms.

Specifications
  • OrganismS. enterica Abony
  • Packaging10/PK
  • Product TypeUSP<61/62> Pharmaceutical Cultures
  • Shelf Life Months (months)18
  • Shipping requirementFrozen ice packs
  • Storage requirementStore between –20 and –10°C
  • StrainNCTC 6017, WDCM 00029
  • DescriptionS. enterica Abony NCTC 6017 Pharmaceutical Culture, USP <61/62>; 10/PK
Reviews
Q&A